NAM QUOC BUI MD
Prescription History 1982994802
Internal Medicine - Medical Oncology in Stanford, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NAM QUOC BUI MD, an active Medical Oncology specialist practicing in Stanford, CA. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 424 documented patient claims. Among these therapy options, the most frequently utilized medication is Imatinib Mesylate, which accounts for 80 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Imatinib Mesylate | 80 | $141.63▼ below CA avg | ▲ More than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 80 Medicare prescriptions for Imatinib Mesylate, about 3.6 times the volume of the typical California prescriber of this medication (22). Medicare paid an average of $141.63 per fill, versus $905.12 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 82 30-Day Fills standardized to 30-day supplies 2,460 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 63 | $8.09▼ below CA avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 63 Medicare prescriptions for Ondansetron Hcl, about 2.3 times the volume of the typical California prescriber of this medication (27.8). Medicare paid an average of $8.09 per fill, versus $14.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 63 30-Day Fills standardized to 30-day supplies 658 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 46 | $605.69▼ below CA avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 46 Medicare prescriptions for Eliquis, about 63% of the volume of the typical California prescriber of this medication (72.9). Medicare paid an average of $605.69 per fill, versus $923.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 52 30-Day Fills standardized to 30-day supplies 1,455 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 35 | $15,227.06▼ below CA avg | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 35 Medicare prescriptions for Ibrance, about 1.3 times the volume of the typical California prescriber of this medication (27.6). Medicare paid an average of $15,227.06 per fill, versus $15,322.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 35 30-Day Fills standardized to 30-day supplies 980 Days of Medication total across all patients in 2024 | |||
| Prednisone | 26 | $3.48▼ below CA avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 26 Medicare prescriptions for Prednisone, about 65% of the volume of the typical California prescriber of this medication (40.3). Medicare paid an average of $3.48 per fill, versus $5.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 30 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 23 | $7.05▼ below CA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 23 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical California prescriber of this medication (43.4). Medicare paid an average of $7.05 per fill, versus $16.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 23 30-Day Fills standardized to 30-day supplies 266 Days of Medication total across all patients in 2024 | |||
| Sunitinib Malate | 23 | $6,143.78 | ▲ More than typical |
About Sunitinib Malate: This medication is used to treat certain types of cancer (kidney, pancreas, and intestinal). Show more ▾ It is also used to treat people who are at high risk of the kidney cancer coming back again after having kidney surgery. Sunitinib works by stopping or slowing the growth of cancer tumors. It also works by slowing the growth of new blood vessels within the tumor. An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA. In 2024, this provider wrote 23 Medicare prescriptions for Sunitinib Malate, about 1.5 times the volume of the typical California prescriber of this medication (15.2). Medicare paid an average of $6,143.78 per fill, versus $3,799.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 612 Days of Medication total across all patients in 2024 | |||
| Pazopanib Hcl | 22 | $9,308.45 | ▲ More than typical |
About Pazopanib Hcl: Pazopanib is used to treat certain types of cancer (kidney, soft tissue sarcoma). Show more ▾ Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth. This medication should not be used by children, especially those younger than 2 years of age, because of the risk of serious side effects. A protein kinase inhibitor. In 2024, this provider wrote 22 Medicare prescriptions for Pazopanib Hcl, about 1.6 times the volume of the typical California prescriber of this medication (13.8). Medicare paid an average of $9,308.45 per fill, versus $6,398.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.3 30-Day Fills standardized to 30-day supplies 670 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 21 | $7.05▼ below CA avg | ▼ Less than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 21 Medicare prescriptions for Prochlorperazine Maleate, about 72% of the volume of the typical California prescriber of this medication (29.2). Medicare paid an average of $7.05 per fill, versus $13.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 21 30-Day Fills standardized to 30-day supplies 226 Days of Medication total across all patients in 2024 | |||
| Lorazepam | 18 | $3.26▼ below CA avg | ▼ Less than typical |
About Lorazepam: This medication is used to treat anxiety. Show more ▾ Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2024, this provider wrote 18 Medicare prescriptions for Lorazepam, about a third of the volume of the typical California prescriber of this medication (43.1). Medicare paid an average of $3.26 per fill, versus $6.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 18 30-Day Fills standardized to 30-day supplies 191 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 15 | $21.90 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 15 Medicare prescriptions for Dexamethasone, about half the volume of the typical California prescriber of this medication (35.2). Medicare paid an average of $21.90 per fill, versus $13.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 150 Days of Medication total across all patients in 2024 | |||
| CabometyxCabozantinib S-Malate | 14 | $23,122.78▼ below CA avg | ▼ Less than typical |
About Cabometyx: This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer). Show more ▾ Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2024, this provider wrote 14 Medicare prescriptions for Cabometyx, about 64% of the volume of the typical California prescriber of this medication (22). Medicare paid an average of $23,122.78 per fill, versus $23,626.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 14 | $15.63 | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 14 Medicare prescriptions for Pantoprazole Sodium, about a quarter of the volume of the typical California prescriber of this medication (64.8). Medicare paid an average of $15.63 per fill, versus $13.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| VitrakviLarotrectinib Sulfate | 12 | $38,735.50 | ≈ Typical |
About Vitrakvi: Larotrectinib is used to treat cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. A TRK kinase inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Vitrakvi, about the same volume as the typical California prescriber of this medication (12.9). Medicare paid an average of $38,735.50 per fill, versus $38,058.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| XalkoriCrizotinib | 12 | $22,812.97 | ≈ Typical |
About Xalkori: Crizotinib is used to treat certain types of cancer (such as lung cancer, anaplastic large cell lymphoma-ALCL). Show more ▾ It is also used to treat a certain type of tumor (inflammatory myofibroblastic tumor-IMT). Crizotinib works by slowing or stopping the growth of cancer or tumor cells. It belongs to a class of drugs known as kinase inhibitors. A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. In 2024, this provider wrote 12 Medicare prescriptions for Xalkori, about the same volume as the typical California prescriber of this medication (13.1). Medicare paid an average of $22,812.97 per fill, versus $19,592.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for NAM QUOC BUI MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Stanford, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
